APA (7th ed.) Citation

Burstein, A. H., Dunn, I., Gooch, A. M., & Valcarce, C. (2020). Effects of azeliragon on ADAS‐cog and CDR domains and individual items in patients with mild Alzheimer's disease and type 2 diabetes (T2D): Human/Human trials: Other. Alzheimer's & dementia: the journal of the Alzheimer's Association, 16(11), 1. https://doi.org/10.1002/alz.041198

Chicago Style (17th ed.) Citation

Burstein, Aaron H., Imogene Dunn, Ann M. Gooch, and Carmen Valcarce. "Effects of Azeliragon on ADAS‐cog and CDR Domains and Individual Items in Patients with Mild Alzheimer's Disease and Type 2 Diabetes (T2D): Human/Human Trials: Other." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 16, no. 11 (2020): 1. https://doi.org/10.1002/alz.041198.

MLA (9th ed.) Citation

Burstein, Aaron H., et al. "Effects of Azeliragon on ADAS‐cog and CDR Domains and Individual Items in Patients with Mild Alzheimer's Disease and Type 2 Diabetes (T2D): Human/Human Trials: Other." Alzheimer's & Dementia: The Journal of the Alzheimer's Association, vol. 16, no. 11, 2020, p. 1, https://doi.org/10.1002/alz.041198.